3P Biopharmaceuticals and Viscofan to collaborate in an innovate advanced therapy project

Monday June 25th, 2018 | General

Cardiomesh is the project in which 3P Biopharmaceuticals and Viscofan are collaborating to develop and manufacture an innovative cell therapy product. 3P Biopharmaceuticals has executed the tuning, the process validation and the GMP manufacturing for clinical use. 3P Biopharmaceuticals, a CDMO specialized in the process development and GMP manufacturing of biologics and cell therapy products, […]